Literature DB >> 17264296

Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs.

Caridad Martinez1, Ted J Hofmann, Roberta Marino, Massimo Dominici, Edwin M Horwitz.   

Abstract

Mesenchymal stromal cells (MSCs) have enormous potential for the regeneration of bone, cartilage, and other tissues derived from primitive mesoderm. Despite extensive research, there is still no single marker that reliably identifies MSCs within the bone marrow. Using immunocytochemistry and flow cytometry, we demonstrate here that the neural ganglioside GD2 is expressed by MSCs either newly isolated from bone marrow or expanded in tissue culture; this finding was supported by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showing expression of the mRNA for GD2 synthase, an essential enzyme for GD2 biosynthesis. GD2 was also expressed on MSCs isolated from adipose tissue, but not on foreskin fibroblasts. Importantly, MSCs were the only cells within normal marrow that expressed this marker. Thus, GD2 appears to be the first reported single surface marker that uniquely distinguishes MSCs from other marrow elements. GD2 may prove valuable to study MSC biology and for the preparation of MSCs for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264296      PMCID: PMC1885494          DOI: 10.1182/blood-2006-08-039347

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.

Authors:  Elena A Jones; Sally E Kinsey; Anne English; Richard A Jones; Liz Straszynski; David M Meredith; Alex F Markham; Andrew Jack; Paul Emery; Dennis McGonagle
Journal:  Arthritis Rheum       Date:  2002-12

2.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

3.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

4.  The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells.

Authors:  F Barry; R Boynton; M Murphy; S Haynesworth; J Zaia
Journal:  Biochem Biophys Res Commun       Date:  2001-11-30       Impact factor: 3.575

5.  Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.

Authors:  I Y Cheung; N K Cheung
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

6.  The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105).

Authors:  F P Barry; R E Boynton; S Haynesworth; J M Murphy; J Zaia
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

7.  Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells.

Authors:  Claudio S Padovan; Klaus Jahn; Tobias Birnbaum; Petra Reich; Petra Sostak; Michael Strupp; Andreas Straube
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

8.  Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs).

Authors:  Ichiro Sekiya; Benjamin L Larson; Jussi T Vuoristo; Jian-Guo Cui; Darwin J Prockop
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

9.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

10.  Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis.

Authors:  Elena A Jones; Anne English; Karen Henshaw; Sally E Kinsey; Alex F Markham; Paul Emery; Dennis McGonagle
Journal:  Arthritis Rheum       Date:  2004-03
View more
  93 in total

Review 1.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

2.  Mesenchymal stem cells: engineering regeneration.

Authors:  Atta Behfar; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

3.  GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Hye Jin Jin; Hae Yun Nam; Yun Kyong Bae; Soo Yeon Kim; I Rang Im; Wonil Oh; Yoon Sun Yang; Soo Jin Choi; Seong Who Kim
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 4.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 5.  Stem cell glycolipids.

Authors:  Makoto Yanagisawa
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

Review 6.  Mesenchymal stem cells: the fibroblasts' new clothes?

Authors:  Muzlifah A Haniffa; Matthew P Collin; Christopher D Buckley; Francesco Dazzi
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

7.  Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Authors:  Venkata Lokesh Battula; Sabrina Treml; Petra M Bareiss; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

Review 8.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

9.  Stem cell platforms for regenerative medicine.

Authors:  Timothy J Nelson; Atta Behfar; Satsuki Yamada; Almudena Martinez-Fernandez; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

10.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.